Latest News and Press Releases
Want to stay updated on the latest news?
-
LOS ANGELES, CA, April 25, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB:ENDV) today announced an agreement with NAMSA – a leading Global Contract Research Organization (CRO) and...
-
PURCHASE, NY, April 25, 2022 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, has named Dr. Vidya Raman-Tangella as chief medical officer to lead...
-
Dublin, April 25, 2022 (GLOBE NEWSWIRE) -- The "Global Digital Health Outlook 2022" report has been added to ResearchAndMarkets.com's offering. Digital health offered extensive support and grew...
-
April 25, 2022 First-quarter highlights Group sales amounted to EUR 3.9 billion, with a 4% comparable sales decline on the back of 9% comparable sales growth in Q1 2021Comparable order intake...
-
April 22, 2022 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that its subsidiary Philips Respironics is notifying customers...
-
PURCHASE, NY, April 22, 2022 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, today announced its agreement with Northwell Health, New York’s largest...
-
New York, April 22, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Testing, Inspection, and Certification Market - Growth, Trends, COVID-19 Impact, and...
-
April 21, 2022 First use of Philips' breakthrough CavaClear solution to help patients with embedded IVC filters, including an athlete suffering from a 16-year old penetrating filterOnly FDA-cleared...
-
Dublin, April 21, 2022 (GLOBE NEWSWIRE) -- The "Global Medical Devices Outlook, 2022" report has been added to ResearchAndMarkets.com's offering. As the healthcare sector adapts to the changes...
-
SAN DIEGO, April 20, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in Investor Summit Group’s Q2...